Kayentis
Kayentis provides eCOA solutions for pharmaceutical companies and tools to help monitoring efficiently.
Kayentis has raised €12M across 2 funding rounds from 3 investors, most recently a round in Mar 2023. Based in Meylan, France; founded 2003; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€12M
€12,000,000
Funding rounds
2
Investors
3
distinct backers
Active since
2020-12
latest 2023-03
Funding by year
EUR raised per yearKayentis — funding by year — interactive chart.
Data table
| Kayentis — funding by year | |
|---|---|
| 2020 | €7.0M |
| 2023 | €5.0M |
Signals
High confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Down/flat last round
Exit likelihood4
base rate 11% (2+ rounds)
- ▼ Old (23y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-28 | Other | €5.0M | Bpifrance,Extens,LBO France | View deal → |
| 2020-12-03 | Other | €7.0M | Extens,LBO France | View deal → |
Investors
3Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData